Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | -2.25% | 15.21 | 1.8% | $131.96m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -3.46% | 21.34 | 14.1% | $125.57m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -1.28% | 145.46 | 6.2% | $78.47m | |
| PRGO | Perrigo Co. Plc | -2.91% | 46.38 | 6.8% | $67.08m | |
| SAGE | SAGE Therapeutics, Inc. | 0.11% | 169.30 | 8.6% | $65.12m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.39% | 129.00 | 2.3% | $52.46m | |
| HZNP | Horizon Pharma plc | -1.77% | 27.19 | 6.7% | $42.82m | |
| PTLA | Portola Pharmaceuticals, Inc. | -3.51% | 27.80 | 7.5% | $41.62m | |
| UTHR | United Therapeutics Corporation | -2.58% | 80.71 | 14.3% | $39.76m | |
| MDCO | Medicines Company | -2.12% | 35.03 | 20.3% | $37.35m | |
| ICLR | ICON Plc | -1.86% | 153.41 | 4.1% | $35.69m | |
| CTLT | Catalent Inc | -3.86% | 53.11 | 2.4% | $35.12m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.30% | 60.90 | 17.2% | $33.13m | |
| ZGNX | Zogenix, Inc. | -2.82% | 50.01 | 9.8% | $22.94m | |
| AERI | Aerie Pharmaceuticals, Inc. | -2.30% | 23.42 | 6.8% | $22.84m |
Company Profile
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.